
Posted on 2월 6, 20252/6/25
Conserving Capital for Pharma Commercialization: Strategic Insights for Biotech Companies

Posted on 1월 22, 20251/22/25
The Path to Maximizing Revenue: How to Simplify Pharmaceutical Commercialization and Find Optimum Success

Posted on 1월 6, 20251/6/25
Beyond Theory: Integrated Commercialization Model Proves Valuable in Launch Success

Posted on 12월 2, 202412/2/24
Patient Centric 3.0: Why a Direct-to-Patient Model Is a Game Changer

Posted on 11월 27, 202411/27/24
From Challenges to Solutions: Breaking Barriers to Revolutionize Patient Services

Posted on 9월 27, 20249/27/24
Behind the Breakthroughs and Practice-Changing Advances: Insights from ESMO 2024

Posted on 9월 5, 20249/5/24
The Promise of a Direct-to-Patient Model – Breaking Down What’s Really Needed for Better Patient Access

Posted on 9월 3, 20249/3/24
The Future of Global Commercialization: Unified, Data-Driven and Patient-Centric

Posted on 8월 5, 20248/5/24
Understanding IDNs and What They Mean to the Pharmaceutical Industry–Q&A with Greg Skalicky

Posted on 7월 17, 20247/17/24